HEPATITIS C

Alinity m HCV Assay

For more information, contact Abbott.

PRODUCT NAME UNIT SIZE ORDER NUMBER GTIN


Accurate quantitation is critical to guide diagnosis to cure Hepatitis C. The Alinity m HCV assay is an in vitro reverse transcription-polymerase chain reaction (RT-PCR) assay to detect and quantitate hepatitis C virus (HCV) RNA in human serum or plasma.
 

  • Dual probe assay within a highly conserved target region of the virus.
  • Accurate quantitation across all genotypes provide confidence in tests results.
  • Streamlined and concurrent HCV confirmation and viral load result from one sample (plasma or serum) provide laboratories and physicians with a solution from Diagnosis to Cure.

Intended Use

The Alinity m HCV assay is an in vitro reverse transcription-polymerase chain reaction (RT-PCR) assay for use with the automated Alinity m System to detect and quantitate hepatitis C virus (HCV) RNA in human serum or plasma. The Alinity m HCV assay is intended for use in the clinical management of HCV-infected patients undergoing antiviral therapy in conjunction with clinical presentation and other laboratory markers. The Alinity m HCV assay may also be used as a diagnostic test to confirm active HCV infection. The results from the Alinity m HCV assay must be interpreted within the context of all relevant clinical and laboratory findings. This assay is not intended to be used in screening blood, blood products, tissue, or organ donors for HCV.

To learn more about Alinity m HCV Assay please visit: https://www.molecular.abbott/int/en/products/infectious-disease/alinity-m-hcv-assay

ALINITY m HCV ASSAY PERFORMANCE
TechnologyRT-PCR
ClaimMonitoring and Confirmatory
Time to first result<115 min
Standardization4th World Health Organization (WHO) International Standard for Hepatitis C Virus
Probe DesignDual probe design; robust genotyping detection and quantitation
Target RegionConserved 5’ UTR Region
Genotypes1,2,3,4,5,6
Specimen typesPlasma: Acid Citrate Dextrose (ACD); K2 EDTA; K3 EDTA; Plasma Preparation Tubes (PPT)
Serum: Serum, Serum Separator Tubes (SST)
Sensitivity
Limit of Detection (LoD)
12 IU/mL
Plasma: Probit Analysis determined that the concentration of HCV RNA detected with 95%
probability was 5.11 IU/mL (95% CI: 3.92 to 8.46 IU/mL)
Serum: Probit Analysis determined that the concentration of HCV RNA detected with 95%
probability was 5.11 IU/mL (95% CI: 4.16 to 7.47 IU/mL)
Linearity12 IU/mL to 200,000,000 IU/mL
Result UnitsIU/mL or Log (IU/mL)
Precision≤ 0.18 Total SD
Sample input volume600μL
SpecificityOverall: 100.0% (95% CI: 99.2 to 100.0%)
ControlsNegative, Low Positive, and High Positive controls–single use tubes
Calibrator2 Calibrator levels–single use tubes
Internal ControlInternal Control Armored RNA (Pumpkin)